OBJECTIVE: The purpose of this study was to determine the identity of the major toxin of Clostridium chauvoei, an important pathogen of cattle causing black leg and to determine its value as a protective antigen in vaccines against myonecrosis. METHODS: Genomic sequence analysis was used to determine potential virulence genes of C. chauvoei. Subsequently, the putative toxin candidate gene was cloned and expressed to obtain recombinant toxin. This toxin was investigated for its cytotoxic activity, hemolysis and its potential as a protective antigen in the guinea pig potency assay. RESULTS: A novel protein toxin, named Clostridium chauvoei toxin A (CctA) that belongs to the family of β-barrel pore forming toxins of the leucocidin superfamily of bacterial toxins was discovered by whole genome sequence analysis. The corresponding gene cctA was found in all strains of C. chauvoei analyzed, isolated from various geographical areas over the globe during the last 50 years, but not in other pathogenic Clostridium species. Native CctA and recombinant rCctA produced in Escherichia coli in the form of a rCctA::NusA fusion protein or thrombin processed rCctA were highly cytotoxic for Embryonic Calf Nasal Epithelial (ECaNEp) cells and had high haemolytic activity against sheep erythrocytes in standard haemolysis assays. Polyclonal anti-rCctA rabbit antibodies fully neutralized the cytotoxic and haemolytic activity, not only of rCctA but also of supernatants from cultures of the various C. chauvoei strains, indicating that CctA is the main cytotoxic and haemolytic substance secreted by C. chauvoei. Using a standard vaccine release procedure, we demonstrated that vaccination of guinea pigs with CctA in the form of a fusion protein with the E. coli heat labile toxin B subunit (rCctA::LTB) as a peptide adjuvant protected the animals against challenge with spores of virulent C. chauvoei. CONCLUSIONS: CctA is the major virulence factor of C. chauvoei and the main protective antigen in vaccines against blackleg.
OBJECTIVE: The purpose of this study was to determine the identity of the major toxin of Clostridium chauvoei, an important pathogen of cattle causing black leg and to determine its value as a protective antigen in vaccines against myonecrosis. METHODS: Genomic sequence analysis was used to determine potential virulence genes of C. chauvoei. Subsequently, the putative toxin candidate gene was cloned and expressed to obtain recombinant toxin. This toxin was investigated for its cytotoxic activity, hemolysis and its potential as a protective antigen in the guinea pig potency assay. RESULTS: A novel protein toxin, named Clostridium chauvoei toxin A (CctA) that belongs to the family of β-barrel pore forming toxins of the leucocidin superfamily of bacterial toxins was discovered by whole genome sequence analysis. The corresponding gene cctA was found in all strains of C. chauvoei analyzed, isolated from various geographical areas over the globe during the last 50 years, but not in other pathogenic Clostridium species. Native CctA and recombinant rCctA produced in Escherichia coli in the form of a rCctA::NusA fusion protein or thrombin processed rCctA were highly cytotoxic for Embryonic Calf Nasal Epithelial (ECaNEp) cells and had high haemolytic activity against sheep erythrocytes in standard haemolysis assays. Polyclonal anti-rCctA rabbit antibodies fully neutralized the cytotoxic and haemolytic activity, not only of rCctA but also of supernatants from cultures of the various C. chauvoei strains, indicating that CctA is the main cytotoxic and haemolytic substance secreted by C. chauvoei. Using a standard vaccine release procedure, we demonstrated that vaccination of guinea pigs with CctA in the form of a fusion protein with the E. coli heat labile toxin B subunit (rCctA::LTB) as a peptide adjuvant protected the animals against challenge with spores of virulent C. chauvoei. CONCLUSIONS:CctA is the major virulence factor of C. chauvoei and the main protective antigen in vaccines against blackleg.
Authors: Carlos A Oliveira Junior; Rodrigo O S Silva; Francisco C F Lobato; Mauricio A Navarro; Francisco A Uzal Journal: J Vet Diagn Invest Date: 2020-02-21 Impact factor: 1.279
Authors: Lorenz Rychener; Saria InAlbon; Steven P Djordjevic; Piklu R Chowdhury; Rosangela E Ziech; Agueda C de Vargas; Joachim Frey; Laurent Falquet Journal: Front Microbiol Date: 2017-06-09 Impact factor: 5.640
Authors: Nicolas E Zaragoza; Camila A Orellana; Glenn A Moonen; George Moutafis; Esteban Marcellin Journal: Toxins (Basel) Date: 2019-09-11 Impact factor: 4.546
Authors: Camila C Abreu; Patricia C Blanchard; John M Adaska; Robert B Moeller; Mark Anderson; Mauricio A Navarro; Santiago S Diab; Francisco A Uzal Journal: J Vet Diagn Invest Date: 2018-10-25 Impact factor: 1.569
Authors: Prasad Thomas; Mostafa Y Abdel-Glil; Anbazhagan Subbaiyan; Anne Busch; Inga Eichhorn; Lothar H Wieler; Heinrich Neubauer; Mathias Pletz; Christian Seyboldt Journal: Front Microbiol Date: 2021-12-09 Impact factor: 5.640